These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 24522075)

  • 1. Re: antitumoral effects of vasoactive intestinal peptide in human renal cell carcinoma xenografts in athymic nude mice.
    Atala A
    J Urol; 2014 Mar; 191(3):866-8. PubMed ID: 24522075
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumoral effects of vasoactive intestinal peptide in human renal cell carcinoma xenografts in athymic nude mice.
    Vacas E; Arenas MI; Muñoz-Moreno L; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
    Cancer Lett; 2013 Aug; 336(1):196-203. PubMed ID: 23664888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide (VIP) inhibits human renal cell carcinoma proliferation.
    Vacas E; Fernández-Martínez AB; Bajo AM; Sánchez-Chapado M; Schally AV; Prieto JC; Carmena MJ
    Biochim Biophys Acta; 2012 Oct; 1823(10):1676-85. PubMed ID: 22728770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: activation of HIF2α in kidney proximal tubule cells causes abnormal glycogen deposition but not tumorigenesis.
    Atala A
    J Urol; 2014 Feb; 191(2):555. PubMed ID: 24411907
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ultrastructural immunocytochemical studies on erythropoietin-producing cells in a human renal carcinoma grown in athymic nude mice and primary monolayer cultures].
    Hagiwara M
    Nihon Hinyokika Gakkai Zasshi; 1987 May; 78(5):834-43. PubMed ID: 3320435
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation between BOLD-MRI and HIF expression level in renal carcinoma.
    Li D; Wang X; Wang S; Cheng J
    Int J Clin Exp Pathol; 2015; 8(10):13759-63. PubMed ID: 26722605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta2 microglobulin: a surprising therapeutic target for prostate cancer and renal cell carcinoma.
    Freeman MR
    J Urol; 2007 Jul; 178(1):10-1. PubMed ID: 17574050
    [No Abstract]   [Full Text] [Related]  

  • 8. [Expression of TGF-beta1 and MMP2 in human renal cell carcinoma and their clinical significance].
    Sun RC; Yang SD; Xu ZQ; Guo D; Mu HJ; Fan QH; Hu Q; Zhang LH; Liang JB
    Zhonghua Bing Li Xue Za Zhi; 2008 Mar; 37(3):184-5. PubMed ID: 18788596
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in levels of metabolic pathway gene expression under conditions of clear cell renal carcinoma.
    Bashmakov VY; Gorbacheva TM; Panevina AV; Solodskikh SA; Moshurov IP; Mikhaylov AA; Maslov AY; Popov VN
    Dokl Biochem Biophys; 2017 May; 474(1):159-161. PubMed ID: 28726105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients.
    Wan F; Wang H; Shen Y; Zhang H; Shi G; Zhu Y; Dai B; Ye D
    Oncotarget; 2015 Sep; 6(29):27378-87. PubMed ID: 26317545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectopic expression of von Hippel-Lindau tumor suppressor induces apoptosis in 786-O renal cell carcinoma cells and regresses tumor growth of 786-O cells in nude mouse.
    Kim M; Yan Y; Lee K; Sgagias M; Cowan KH
    Biochem Biophys Res Commun; 2004 Jul; 320(3):945-50. PubMed ID: 15240140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-490-5p suppresses tumour growth in renal cell carcinoma through targeting PIK3CA.
    Chen K; Zeng J; Tang K; Xiao H; Hu J; Huang C; Yao W; Yu G; Xiao W; Guan W; Guo X; Xu H; Ye Z
    Biol Cell; 2016 Feb; 108(2):41-50. PubMed ID: 26559013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.
    Rekasi Z; Schally AV; Plonowski A; Czompoly T; Csernus B; Varga JL
    Prostate; 2001 Aug; 48(3):188-99. PubMed ID: 11494334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Zhu et al.: The expression and evaluation of androgen receptor in human renal cell carcinoma (Urology 2014;83:510.e19-24).
    Putz J; Wirth MP; Froehner M; Jahn S
    Urology; 2014 Sep; 84(3):734-5. PubMed ID: 25168563
    [No Abstract]   [Full Text] [Related]  

  • 15. EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression.
    Gu B; Ding Q; Xia G; Fang Z
    Oncol Rep; 2009 Mar; 21(3):635-40. PubMed ID: 19212621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide induces oxidative stress and suppresses metastatic potential in human clear cell renal cell carcinoma.
    Vacas E; Bajo AM; Schally AV; Sánchez-Chapado M; Prieto JC; Carmena MJ
    Mol Cell Endocrinol; 2013 Jan; 365(2):212-22. PubMed ID: 23123564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway.
    Wang H; Qu Y; Dai B; Zhu Y; Shi G; Zhu Y; Shen Y; Zhang H; Ye D
    PLoS One; 2017; 12(8):e0180862. PubMed ID: 28846693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VHL loss predicts response to Aurora kinase A inhibitor in renal cell carcinoma cells.
    Ding XF; Zhou J; Chen G; Wu YL
    Mol Med Rep; 2018 Jul; 18(1):1206-1210. PubMed ID: 29845253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of pituitary tumor transforming gene in human renal clear cell carcinoma and its significance].
    Tang MH; Tan J; Cui FL
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1712-4. PubMed ID: 20650808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vasoactive intestinal peptide on isolated perfused rat kidney.
    Rosa RM; Silva P; Stoff JS; Epstein FH
    Am J Physiol; 1985 Nov; 249(5 Pt 1):E494-7. PubMed ID: 4061639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.